Marviol

Desogestrel, the active ingredient in Marviol, is a combined estrogen‑progestogen oral contraceptive presented as an oral tablet for oral use. It is indicated for the prevention of pregnancy and for regulation of menstrual cycles in women of reproductive age.

GNH USA supplies Marviol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established quality‑assurance processes and regulatory approvals across EU and other markets. The company provides reliable logistics, batch traceability, and technical support to ensure consistent product availability for healthcare providers.

Marviol, a combined estrogen‑progestogen oral contraceptive, is used to manage reproductive hormone pathways. - Prevention of pregnancy: provides reliable contraception by suppressing ovulation and preventing fertilisation. - Regulation of menstrual cycles: stabilises cycle length and reduces irregular bleeding. - Treatment of acne: improves hormonal acne by decreasing androgen‑driven sebum production. - Management of endometriosis: alleviates pain and limits lesion growth through hormonal suppression.

Common Side Effects: - Nausea: mild to moderate stomach upset, especially during the first cycles. - Breast tenderness: temporary swelling or discomfort of the breasts. - Headache: occasional tension‑type or migraine‑like headaches. - Spotting: irregular light bleeding between periods. Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: risk of heart attack or stroke. - Severe hypertension: sudden, high blood pressure requiring medical attention.

Before prescribing Marviol, clinicians should consider the following precautions. - Thrombotic risk assessment: evaluate personal or family history of clotting disorders. - Blood pressure monitoring: ensure hypertension is controlled before use. - Smoking status: advise women over 35 who smoke to discontinue smoking. - Liver function review: avoid use in severe hepatic impairment. - Drug history check: screen for medications that may reduce contraceptive efficacy. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Marviol may interact with several medicines; awareness of the interaction level guides clinical decisions. Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may markedly reduce contraceptive effectiveness. - Anticoagulants (e.g., warfarin): hormonal changes can alter anticoagulant response. - Antiretrovirals (e.g., efavirenz): may lower plasma hormone levels. - St. John’s wort: herbal inducer that can compromise efficacy. Moderate Interactions (Monitor Closely): - SSRIs (e.g., fluoxetine): may increase bleeding tendency. - Azole antifungals (e.g., ketoconazole): can raise hormone concentrations, increasing side‑effect risk. - Diuretics: may affect fluid balance and blood pressure control.